trial

Neurobiological Effects of Oxytocin in Schizophrenia - Imaging Study

NCTId NCT04158167
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 90 (actual)
Sponsored by National Institute of Mental Health and Neuro Sciences, India
Primary completion 2018-12-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
90 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2013-09-01
Primary completion
2018-12-30
Eligibility
MALE · 18 Years · 50 Years

Interventions & indications

Drugs
Oxytocin

Sponsors

National Institute of Mental Health and Neuro Sciences, IndiaLead Sponsor

Sites

1 total
Bangalore, India

Facts & assertions

4 sourced
Enrollment
90
Phase
NA
Primary Completion Date
2018-12-30
Status
COMPLETED
relationships
The graph out of here
drug
Oxytocin
drug
lead_sponsor
National Institute of Mental Health and Neuro Sciences, India
company
indication
Schizophrenia
indication
Schizophrenia
indication